PH48 Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances

International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2025-01

postcoordination

synonyms

• Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances
• drug related harm
• Exposure to or harmful effects of undetermined intent of systemic antibiotics
• Exposure to or harmful effects of undetermined intent of penicillins
• Exposure to or harmful effects of undetermined intent of cephalosporins or other beta-lactam antibiotics
• Exposure to or harmful effects of undetermined intent of chloramphenicol group
• Exposure to or harmful effects of undetermined intent of macrolides
• Exposure to or harmful effects of undetermined intent of tetracyclines
• Exposure to or harmful effects of undetermined intent of aminoglycosides
• Exposure to or harmful effects of undetermined intent of rifampicins
• Exposure to or harmful effects of undetermined intent of antifungal antibiotics, systemically used
• Exposure to or harmful effects of undetermined intent of other systemic anti-infectives or antiparasitics
• Exposure to or harmful effects of undetermined intent of sulfonamides
• Exposure to or harmful effects of undetermined intent of antimycobacterial drugs
• Exposure to or harmful effects of undetermined intent of antimalarials or drugs acting on other blood protozoa
• Exposure to or harmful effects of undetermined intent of other antiprotozoal drugs
• Exposure to or harmful effects of undetermined intent of anthelminthics
• Exposure to or harmful effects of undetermined intent of antiviral drugs
• Exposure to or harmful effects of undetermined intent of hormones or their synthetic substitutes or antagonists, not elsewhere classified
• Exposure to or harmful effects of undetermined intent of glucocorticoids or synthetic analogues
• Exposure to or harmful effects of undetermined intent of thyroid hormones or substitutes
• Exposure to or harmful effects of undetermined intent of antithyroid drugs
• Exposure to or harmful effects of undetermined intent of insulin or oral hypoglycaemic drugs
• harmful effect of antidiabetic drugs, undetermined intent
• Exposure to or harmful effects of undetermined intent of oral contraceptives
• Exposure to or harmful effects of undetermined intent of other estrogens or progestogens
• Exposure to or harmful effects of undetermined intent of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified
• Exposure to or harmful effects of undetermined intent of androgens or anabolic congeners
• Exposure to or harmful effects of undetermined intent of unspecified hormones or synthetic substitutes
• Exposure to or harmful effects of undetermined intent of anterior pituitary hormones
• Harmful effect of adenohypophyseal hormones, undetermined intent
• Exposure to or harmful effects of undetermined intent of other hormones or synthetic substitutes
• Exposure to or harmful effects of undetermined intent of unspecified hormone antagonists
• Exposure to or harmful effects of undetermined intent of other hormone antagonists
• Exposure to or harmful effects of undetermined intent of drugs primarily affecting the autonomic nervous system
• Exposure to or harmful effects of undetermined intent of anticholinesterase agents
• Exposure to or harmful effects of undetermined intent of other parasympathomimetics
• harmful effect of cholinergics, undetermined intent
• Exposure to or harmful effects of undetermined intent of ganglionic blocking drugs
• Exposure to or harmful effects of undetermined intent of other parasympatholytics or spasmolytics
• harmful effect of anticholinergics or antimuscarinics, undetermined intent
• Exposure to or harmful effects of undetermined intent of predominantly alpha-adrenoreceptor agonists
• Exposure to or harmful effects of undetermined intent of predominantly beta-adrenoreceptor agonists
• Exposure to or harmful effects of undetermined intent of alpha-adrenoreceptor antagonists
• Exposure to or harmful effects of undetermined intent of beta-adrenoreceptor antagonists
• Exposure to or harmful effects of undetermined intent of centrally-acting or adrenergic-neuron-blocking agents
• Exposure to or harmful effects of undetermined intent of agents primarily affecting blood constituents
• Exposure to or harmful effects of undetermined intent of diphenhydramine
• Exposure to or harmful effects of undetermined intent of other H1-receptor antagonists
• Exposure to or harmful effects of undetermined intent of antiallergic or antiemetic drugs
• Exposure to or harmful effects of undetermined intent of antineoplastic antimetabolites
• Exposure to or harmful effects of undetermined intent of antineoplastic natural products
• Exposure to or harmful effects of undetermined intent of other antineoplastic drugs
• Exposure to or harmful effects of undetermined intent of immunosuppressive agents
• Exposure to or harmful effects of undetermined intent of vitamin B12, folic acid or other anti-megaloblastic-anaemia preparations
• Exposure to or harmful effects of undetermined intent of enzymes
• Exposure to or harmful effects of undetermined intent of iron or its compounds
• Exposure to or harmful effects of undetermined intent of anticoagulants
• Exposure to or harmful effects of undetermined intent of antithrombotic drugs
• harmful effect of platelet aggregation inhibitors, undetermined intent
• Exposure to or harmful effects of undetermined intent of thrombolytic drug
• Exposure to or harmful effects of undetermined intent of anticoagulant antagonists, vitamin K or other coagulants
• Exposure to or harmful effects of undetermined intent of other fibrinolysis-affecting drugs
• Exposure to or harmful effects of undetermined intent of natural blood or blood products
• Exposure to or harmful effects of undetermined intent of acidifying or alkalising agents
• Exposure to or harmful effects of undetermined intent of other primarily systemic agents, not elsewhere classified
• Exposure to or harmful effects of undetermined intent of plasma substitutes
• Exposure to or harmful effects of undetermined intent of agents primarily affecting the cardiovascular system
• Exposure to or harmful effects of undetermined intent of cardiac-stimulant glycosides or drugs of similar action
• Exposure to or harmful effects of undetermined intent of calcium-channel blockers
• Exposure to or harmful effects of undetermined intent of other antidysrhythmic drugs
• Exposure to or harmful effects of undetermined intent of nitroglycerin, nitroglycerol, medicinal
• Exposure to or harmful effects of undetermined intent of other coronary vasodilators
• Exposure to or harmful effects of undetermined intent of angiotensin-converting-enzyme inhibitors
• Exposure to or harmful effects of undetermined intent of other antihypertensive drugs
• Exposure to or harmful effects of undetermined intent of antihyperlipidemic or antiarteriosclerotic drugs
• Exposure to or harmful effects of undetermined intent of peripheral vasodilators
• Exposure to or harmful effects of undetermined intent of antivaricose drugs, including sclerosing agents
• Exposure to or harmful effects of undetermined intent of agents primarily affecting the gastrointestinal system
• Exposure to or harmful effects of undetermined intent of histamine H2-receptor blockers
• Exposure to or harmful effects of undetermined intent of other antacids or anti-gastric-secretion drugs
• Exposure to or harmful effects of undetermined intent of stimulant laxatives
• Exposure to or harmful effects of undetermined intent of saline or osmotic laxatives
• Exposure to or harmful effects of undetermined intent of other laxatives
• Exposure to or harmful effects of undetermined intent of digestants
• Exposure to or harmful effects of undetermined intent of antidiarrhoeal drugs
• Exposure to or harmful effects of undetermined intent of emetics
• Exposure to or harmful effects of undetermined intent of agents primarily acting on smooth or skeletal muscles or the respiratory system
• Exposure to or harmful effects of undetermined intent of oxytocic drugs
• Exposure to or harmful effects of undetermined intent of skeletal muscle relaxants
• harmful effect of neuromuscular blocking agents, undetermined intent
• Exposure to or harmful effects of undetermined intent of other drugs acting on muscles
• Exposure to or harmful effects of undetermined intent of unspecified drugs acting on muscles
• Exposure to or harmful effects of undetermined intent of antitussives
• Exposure to or harmful effects of undetermined intent of expectorants
• Exposure to or harmful effects of undetermined intent of other anti-common-cold drugs
• Exposure to or harmful effects of undetermined intent of salbutamol
• Exposure to or harmful effects of undetermined intent of aminophylline, theophylline
• Exposure to or harmful effects of undetermined intent of terbutaline
• Exposure to or harmful effects of undetermined intent of antiasthmatics, not elsewhere classified
• Exposure to or harmful effects of undetermined intent of topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs
• Exposure to or harmful effects of undetermined intent of topical corticosteroid preparations
• Exposure to or harmful effects of iodine, antiseptic, undetermined intent
• Exposure to or harmful effects of undetermined intent of silver nitrate
• Exposure to or harmful effects of undetermined intent of other local antifungal, anti-infective or anti-inflammatory drugs
• Exposure to or harmful effects of undetermined intent of antipruritics
• Exposure to or harmful effects of undetermined intent of methyl salicylate
• Exposure to or harmful effects of undetermined intent of other local astringents or local detergents
• Exposure to or harmful effects of undetermined intent of emollients, demulcents or protectants
• Exposure to or harmful effects of undetermined intent of podophyllin
• Exposure to or harmful effects of undetermined intent of keratolytics, keratoplastics, or other hair treatment drugs or preparations
• Exposure to or harmful effects of undetermined intent of ophthalmological drugs or preparations
• Exposure to or harmful effects of undetermined intent of otorhinolaryngological drugs or preparations
• Exposure to or harmful effects of undetermined intent of fluoride preparations
• Exposure to or harmful effects of undetermined intent of other dental drugs, topically applied
• Exposure to or harmful effects of undetermined intent of camphor
• Exposure to or harmful effects of undetermined intent of agents primarily affecting water-balance or mineral or uric acid metabolism
• Exposure to or harmful effects of undetermined intent of mineralocorticoids
• Exposure to or harmful effects of undetermined intent of mineralocorticoids antagonists
• Exposure to or harmful effects of undetermined intent of loop diuretics
• harmful effect of high-ceiling diuretics, undetermined intent
• Exposure to or harmful effects of undetermined intent of carbonic-anhydrase inhibitors
• Exposure to or harmful effects of undetermined intent of benzothiadiazine derivatives
• harmful effect of thiazides, undetermined intent
• Exposure to or harmful effects of undetermined intent of other diuretics
• Exposure to or harmful effects of undetermined intent of electrolytic, caloric or water-balance agents
• Exposure to or harmful effects of undetermined intent of mineral salts, not elsewhere classified
• Exposure to or harmful effects of undetermined intent of drugs affecting uric acid metabolism
• Exposure to or harmful effects of undetermined intent of vitamin D or derivatives
• Exposure to or harmful effects of undetermined intent of bisphosphonates
• Exposure to or harmful effects of undetermined intent of appetite depressants
• Exposure to or harmful effects of undetermined intent of antidotes or chelating agents, not elsewhere classified
• Exposure to or harmful effects of undetermined intent of disulfiram
• Exposure to or harmful effects of undetermined intent of alcohol deterrents, not elsewhere classified
• Exposure to or harmful effects of undetermined intent of X-ray contrast media
• Exposure to or harmful effects of undetermined intent of MRI contrast agents
• Exposure to or harmful effects of undetermined intent of agents used for other scanning techniques
• Exposure to or harmful effects of undetermined intent of other diagnostic agents
• Exposure to or harmful effects of undetermined intent of lipotropic drugs
• Exposure to or harmful effects of undetermined intent of pharmaceutical excipients
• Exposure to or harmful effects of undetermined intent of herbal preparations or formulas
• Exposure to or harmful effects of undetermined intent of dietary supplements, vitamins or minerals
• Exposure to or harmful effects of undetermined intent of complementary or traditional medicines, not elsewhere classified
• Exposure to or harmful effects of undetermined intent of complementary or traditional medicines, unspecified
• Exposure to or harmful effects of undetermined intent of vaccines immunoglobulins or other biological substances
• Exposure to or harmful effects of undetermined intent of BCG vaccine
• Exposure to or harmful effects of undetermined intent of typhoid or paratyphoid vaccine
• Exposure to or harmful effects of undetermined intent of cholera vaccine
• Exposure to or harmful effects of undetermined intent of plague vaccine
• Exposure to or harmful effects of undetermined intent of tetanus vaccine
• Exposure to or harmful effects of undetermined intent of diphtheria vaccine
• Exposure to or harmful effects of undetermined intent of haemophilus influenzae type b vaccines
• Exposure to or harmful effects of undetermined intent of pertussis vaccine, including combinations with a pertussis component
• Exposure to or harmful effects of undetermined intent of mixed bacterial vaccines without a pertussis component
• Exposure to or harmful effects of undetermined intent of other or unspecified bacterial vaccines
• Exposure to or harmful effects of undetermined intent of smallpox vaccines
• Exposure to or harmful effects of undetermined intent of measles vaccines
• Exposure to or harmful effects of undetermined intent of mumps vaccines
• Exposure to or harmful effects of undetermined intent of rubella vaccines
• Exposure to or harmful effects of undetermined intent of polio vaccines
• Exposure to or harmful effects of undetermined intent of yellow fever vaccines
• Exposure to or harmful effects of undetermined intent of hepatitis A vaccines
• Exposure to or harmful effects of undetermined intent of hepatitis B vaccines
• Exposure to or harmful effects of undetermined intent of influenza vaccines
• Exposure to or harmful effects of undetermined intent of rotavirus vaccines
• Exposure to or harmful effects of undetermined intent of human papillomavirus vaccines
• Exposure to or harmful effects of undetermined intent of other viral vaccines
• Exposure to or harmful effects of undetermined intent of rickettsial vaccines
• Exposure to or harmful effects of undetermined intent of protozoal vaccines
• Exposure to or harmful effects of undetermined intent of hepatitis B immune globulin
• Exposure to or harmful effects of undetermined intent of antivenin, antivenom
• Exposure to or harmful effects of undetermined intent of immunoglobulin, not elsewhere classified
• Exposure to or harmful effects of undetermined intent of other specified vaccines
• Exposure to or harmful effects of undetermined intent of unspecified vaccines

Thank you for choosing Find-A-Code, please Sign In to remove ads.